Early Detection of the Pathogenetic Variants of Homologous Recombination Repair Genes in Prostate Cancer: Critical Analysis and Experimental Design

It has been shown that the pathogenic variants (PVs) of the DNA Damage Response (DDR) genes, whether of a germinal or somatic nature, represent a predictive biomarker of high sensitivity to treatment with inhibitors of the enzyme poly-ADP-ribose polymerase (PARP) in patients with hormone-resistant m...

Full description

Bibliographic Details
Published in:	Biology
Main Authors:	Irene Bottillo, Alessandro Sciarra, Giulio Bevilacqua, Alessandro Gentilucci, Beatrice Sciarra, Valerio Santarelli, Stefano Salciccia, Francesca Bacigalupo, Francesco Pastacaldi, Maria Pia Ciccone, Laura De Marchis, Daniele Santini, Fabio Massimo Magliocca, Elisabetta Merenda, Flavio Forte, Paola Grammatico
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Subjects:	prostate neoplasm BRCA gene DDR gene
Online Access:	https://www.mdpi.com/2079-7737/14/2/117

Similar Items

Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
by: Alessandro Sciarra, et al.
Published: (2023-08-01)

Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration
by: Jun He, et al.
Published: (2024-06-01)

Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer
by: Marcelo Moreno, et al.
Published: (2023-08-01)

Breast Cancer; Clinical Spectrum and Genetic Abnormalities in Women of Reproductive Age-Retrospective Study.
by: Syed Muhammad Ali Haider, et al.
Published: (2023-12-01)

The Protein Corona on Nanoparticles for Tumor Targeting in Prostate Cancer—A Review of the Literature and Experimental Trial Protocol
by: Giulio Bevilacqua, et al.
Published: (2024-12-01)

Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
by: Lauren Clarfield, et al.
Published: (2022-03-01)

Pesquisa e propriedade intelectual envolvendo material humano: afinal, de quem são nossos genes?
by: Mariana de Melo Santos, et al.
Published: (2016-03-01)

Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma
by: Sami Shoucair, et al.
Published: (2022-01-01)

Causative Genes of Homologous Recombination Deficiency (HRD)-Related Breast Cancer and Specific Strategies at Present
by: Seigo Nakamura, et al.
Published: (2025-02-01)

Clinicopathological Characteristics of Patients with BRCA Mutation Breast Cancer in North Sumatera: Case Report
by: Dedy Hermansyah, et al.
Published: (2023-04-01)

MANAGEMENT OF BREAST CANCER WITH BRCA GENE MUTATION
by: I Wayan Ari Sumardika, et al.
Published: (2013-09-01)

Next Generation Disarmament, Demobilization and Reintegration
by: Robert Muggah, et al.
Published: (2015-05-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

A case–control study of BRCA1 founder mutations 185delAG and 5382insC in a cohort of Egyptian ovarian cancer patients using pyrosequencing technique
by: Mohamed M. Rizk, et al.
Published: (2022-01-01)

Das Sportwunder DDR aus der schwedischen Perspektive. Eine linguistische Diskursanalyse
by: Charlotta Seiler Brylla
Published: (2013-12-01)

Essential role of the BRCA2B gene in somatic homologous recombination in Arabidopsis thaliana
by: Padinhatta Purayil Amritha, et al.
Published: (2023-12-01)

Relationship Between PTEN Gene Pathway and Breast Cancer
by: Demet Akdeniz, et al.
Published: (2018-08-01)

Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases
by: Ma Y, et al.
Published: (2025-02-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Phenocopy in a patient with triple negative breast cancer: a case report
by: Gustavo Henrique Morcelli da Costa, et al.
Published: (2023-11-01)

Planejamento Familiar em Mulheres de Alto Risco de Câncer de Mama
by: Maria Fernanda de Matos Maluf, et al.
Published: (2008-12-01)

Implicações éticas dos testes genéticos de suscetibilidade ao câncer de mama
by: Nedy Maria Branco Cerqueira Neves, et al.
Published: (2022-11-01)

Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends
by: Thapa B, et al.
Published: (2024-09-01)

A contribuição dos genes BRCA na predisposição hereditária ao câncer de mama
by: Luis Cláudio Belo Amendola, et al.
Published: (2005-12-01)

Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge
by: Heng Zhang, et al.
Published: (2025-06-01)

Homologs of breast cancer genes in plants
by: Oliver eTrapp, et al.
Published: (2011-06-01)

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)

Efficacy and safety of treatment regimens for patients with metastatic, locally advanced, or recurrent breast cancer carrying BRCA1/BRCA2 pathogenic variants: A network meta-analysis
by: Yingxuan Zhu, et al.
Published: (2023-02-01)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
by: LILIAN JARA, et al.
Published: (2002-01-01)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01)

Straffrätt och kriminalpolitik i DDR
by: Erich Buchholz
Published: (1988-08-01)

Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients
by: Verena Lieb, et al.
Published: (2022-11-01)

Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance
by: Stefano Salciccia, et al.
Published: (2023-07-01)

Oncotype DX Recurrence Score and Germline BRCA Variants in Patients with HR-Positive/HER2-Negative Early Breast Cancer: A Retrospective Observational Study
by: Stefania Morganti, et al.
Published: (2025-04-01)

Investigating the Role of BRCA2 Gene in Predicting Prostate Cancer Progression in Tehran Hospitals in 2021-2024
by: Tayebeh Hassanimanesh, et al.
Published: (2025-06-01)

BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients
by: Karolina Prajzendanc, et al.
Published: (2025-06-01)

Malignant Transformation of Heterotopic Pancreatic Tissue in a Patient with BRCA2 Mutation
by: Danson Xue Wei Yeo, et al.
Published: (2021-01-01)

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
by: Mev Dominguez-Valentin, et al.
Published: (2018-01-01)

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
by: Patricia Ashton-Prolla, et al.
Published: (2014-01-01)

Genetic Predictors of Malignancy: a Literature Review
by: A. V. Pushkarev, et al.
Published: (2021-05-01)